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Abstract
Background: Taenia solium, T. asiatica and T. saginata tapeworms cause human taeniasis and are the origin of
porcine and bovine cysticercosis. Furthermore, T. solium eggs can cause human cysticercosis, with neurocysticercosis
being the most serious form of the disease. These helminth infections are neglected tropical diseases and are endemic
in several countries in the Americas, Asia and Africa. As a result of globalization, migration in particular, the infections
have been extending to non-endemic territories. Species-specific diagnosis of taeniasis is subject to drawbacks that
could be resolved using molecular approaches. In the present study, conventional and real-time amplification protocols
(cPCR and qPCR) based on the T. saginata HDP2 sequence were applied in the differential diagnosis of taeniasis
(T. saginata, T. solium) in both fecal samples and proglottids expelled by patients. The HDP2 homolog in T. solium
was cloned and characterized.
Results: Semi-nested cPCR and qPCR (Sn-HDP2 cPCR and Sn-HDP2 qPCR) amplified T. saginata and T. solium DNA,
with an analytical sensitivity of 40 and 400 fg, respectively, and identically in both protocols. Eighteen taeniasis patients
were diagnosed directly with T. saginata or T. solium, either from proglottids or fecal samples with/without eggs
(detected using microscopy), based on the optimized Sn-HDP2 qPCR. After cloning, the T. solium HDP2 homolog
sequence was confirmed to be a ribosomal sequence. The HDP2 fragment corresponded to a non-transcribed
sequence/external transcribed repeat (NTS/ETS) of ribosomal DNA. Compared with the T. saginata HDP2 homolog, the
T solium HDP2 sequence lacked the first 900 nt at the 5′ end and showed nucleotide substitutions and small deletions.
Conclusions: Sn-HDP2 cPCR and Sn-HDP2 qPCR were set up for the diagnosis of human taeniasis, using proglottids
and fecal samples from affected patients. The new Sn-HDP2 qPCR protocol was the best option, as it directly
differentiated T. saginata from T. solium. The diagnosis of an imported T. solium-taeniasis case and nine European
T. saginata cases was relevant. Finally, the cloning and sequencing of the T. solium HDP2 fragment confirmed that
HDP2 was part of a ribosomal unit.
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Background
Taenia solium, T. asiatica and T. saginata tapeworms
cause human taeniasis and are the origin of porcine and
bovine cysticercosis [1]. In addition, T. solium eggs can
cause cysticercosis in humans, with neurocysticercosis
being the most serious form of the disease [2]. These
helminth infections are neglected tropical diseases and
are endemic in several countries in the Americas, Asia
and Africa [2, 3]. As a result of globalization, human mi-
gration in particular, taeniasis and cysticercosis have
been extending to other regions where they had been
eliminated during the 20th century [4].
The impact of taeniasis/cysticercosis on health and
socio-economic development in endemic regions is sig-
nificant enough that several initiatives have been under-
taken to control them [5, 6]. Sensitive and specific
diagnostic tools are therefore of considerable importance
in aiding these initiatives [7]. Species-specific identifica-
tion of Taenia spp. is a fundamental component of the
diagnosis of taeniasis, and suitable treatment and preven-
tion of the transmission of cysticercosis play a key role, as
human T. solium carriers are the origin of cysticercosis. In
this regard, molecular techniques are excellent alternatives
that complement immunodiagnosis and traditional para-
sitological methods, which are affected by specificity (e.g.
Taenia coproantigen ELISA) and specificity/sensitivity
(e.g. Taenia eggs and microscopy) [1]. The supporting in-
formation (Additional file 1: Table S1; Additional file 2:
Table S2) summarizes the molecular targets used in the
identification of Taenia spp. The targets include mito-
chondrial and ribosomal DNA, repetitive DNA sequences
and/or genes encoding relevant antigens. Based upon
these sequences, we investigated the T. saginata HDP2 re-
petitive sequence [8], which hybridized differentially with
DNA from T. saginata (3 ng) and T. solium (25 ng) [8].
The T. saginata HDP2 fragment was sequenced and fur-
ther characterized [9], and it was found that the 5′ end of
HDP2 (5PHDP2, approximately 1000 bp) was not present
in the homologous sequence of T. solium. The informa-
tion extracted was used to design cPCRs, which were in
turn used for species-specific identification of the taeniid
[9, 10], and for the detection of T. solium DNA in cerebro-
spinal fluid from neurocysticercosis patients [11]. Next,
several T. saginata and T. asiatica isolates were analyzed,
and it was confirmed that the HDP2 fragment was poly-
morphic owing to a variable representation of partially re-
peated sequences, rather than to nucleotide sequence
divergence, thus proving its relevance as a diagnostic tar-
get [12, 13]. Prior to this study, the PCRs derived from
HDP2 had not been applied to samples from taeniasis pa-
tients. In addition, the homolog of HDP2 in T. solium had
not been characterized.
In the present study, both Sn-HDP2 cPCR and Sn-
HDP2 qPCR were performed based on the T. saginata
HDP2 sequence, and their analytical sensitivities were
determined using purified T. saginata and T. solium
genomic DNA (gDNA). These protocols were applied to
carry out the species-specific diagnosis of taeniasis in
both fecal samples and proglottids expelled by infected
humans. Furthermore, the HDP2 homologous sequence
from T. solium was cloned and characterized.
Methods
Parasite material
A frozen T. solium adult was provided by Professor
Elizabeth Ferrer, Universidad de Carabobo, Valencia,
Venezuela. Taenia solium cysticerci were a gift from
Professor Edda L. Sciutto, Instituto de Investigaciones
Biomédicas, Universidad Nacional Autónoma de México,
México DF, México. A T. saginata adult was supplied by
Dr Sabino Puente Puente, Hospital La Paz-Carlos III,
Madrid, Spain. The parasitic material was stored at -80 °C
until use; genomic DNA (gDNA) from T. saginata and T.
solium samples was isolated as described elsewhere [14].
Clinical samples
The study samples comprised 8 fecal samples and 16
proglottids (fragmented or non-preserved, unidentifiable
by morphology) from 18 individuals with taeniasis
(Table 1). In the case of stool, 1–3 serial samples per pa-
tient were used. The clinical samples belonged to collec-
tion C.0003989, which is registered at the ISCIII
Biobank, and were managed following current ethical
recommendations, according to Spanish Royal Decree
1716/2011 about the requirements of biobanks in bio-
medical research.
Prior to DNA extraction, 1 g of each stool sample
was suspended in 8 ml of saline solution and concen-
trated using Bioparapred-Midicolumns (Leti Diagnos-
tics, Barcelona, Spain). The supernatants were then
discarded, and 200 mg of the pellets was used for total
DNA extraction [15]. DNA from serial fecal samples
and proglottids was purified using QIAamp DNA ex-
traction kits (QIAamp Fast DNA Stool Mini Kit and
QIAamp DNA Mini Kit, respectively) (Qiagen, Venlo,
the Netherlands), following the manufacturer’s recom-
mendations. DNA samples were eluted in 200 μl of water.
Microscopy analysis
Clinical samples were analyzed by optical microscopy ac-
cording to standard protocols [16].
Amplification protocols (PCR): Sn-HDP2 cPCR and Sn-HDP2
qPCR
The Sn-HDP2 cPCR used F2,2 (5′-CTT CTC AAT TCT
AGT CGC TGT GGT CAG-3′) and R10 (5′-GAG GAA
TAG ATG GAT GAA GGG-3′) as primers for the first
amplification and F2,2 and R1m (5′-GAC GAA GAA
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TGG AGT TGA AGG-3′) as primers for the second
amplification. The cPCR was performed as previously
described [11]. The first cPCR reaction was performed
using 40 μl of fecal DNA, or 15 μl of proglottid DNA as
template. Negative and positive controls were performed
for each assay. For the second amplification, 2 μl of a
1:500 dilution in water from the first amplification was
used. Amplicons were sequenced, as described below.
The primers used in Sn-HDP2 qPCR were the same as
for Sn-HDP2 cPCR. The first reaction was performed in
a total volume of 20 μl, containing 2 μl of 10× LightCy-
cler® FastStart DNA Master SYBR Green I (Roche Diag-
nostics, Barcelona, Spain). In addition, 1 μl of each
primer at 10 μM, DNA template (15 μl fecal DNA plus
1 μl of sterile water and 5 μl of DNA template from pro-
glottids plus 11 μl of sterile water). Negative and positive
controls were performed for each assay. The thermocy-
cler conditions were as follows: 95 °C for 10 min; 40 -
cycles of 95 °C for 10 s, 56 °C for 15 s, 72 °C for 20 s;
72 °C to 99 °C (continuous acquisition). For the second
amplification, the reaction was carried out in a total vol-
ume of 20 μl using the same reagents as for the first
qPCR and 2 μl of a 1:500 dilution in water from the first
reaction. The thermocycler conditions of the second
amplification were as follows: 95 °C for 10 min; 35 cycles
of 95 °C for 10 s, 58 °C for 15 s, 72 °C for 20 s; 72 °C to
99 °C (continuous acquisition). Amplicons were se-
quenced, and melt curves were estimated.
Analytical sensitivity of Sn-HDP2 cPCR and Sn-HDP2 qPCR
Serial dilutions (1:10) from purified T. saginata and T.
solium gDNA prepared from 1 ng/μl to 1 fg/μl were
amplified using the two amplification protocols.
Construction of a T. solium genomic library
gDNA from T. solium cysticerci was used to prepare a
parasite DNA library with Lambda Fix II vector follow-
ing a previously described protocol [14].
Cloning of the T. solium HDP2 sequence
Two strategies were used to clone the T. solium HDP2 se-
quence: (i) T. solium gDNA library screening with the T.
saginata HDP2 homolog probe [9, 13] and (ii) cPCR-
cloning using T. solium gDNA as a template and riboso-
mal DNA-specific primers derived from T. solium 28S
and 18S ribosomal DNA sequences. The supporting infor-
mation (Additional file 3: Table S3) includes the character-
istics of both universal and walking primers used to
complete the sequencing of T. solium HDP2 subclones,
which were obtained by library screening. In addition,
Table 1 Species-specific diagnosis of human taeniosis using Sn-HDP2 cPCRs and Sn-HDP2 qPCR. In serial fecal samples, the compari-
son of both PCR and microcopy observation (MO) results is included





Sn HDP2 cPCRa & qPCR MO
1 3 3 1 2 3
1 Spain Female 18 T. saginata + +
2 France Male 47 T. saginata + +
3 Spain Female 34 T. saginata + + + + – –
4 Spain Male 33 T. saginata + +
5 Spain Male 37 T. saginata + +
6 Spain Female 29 T. saginata + +
7 Spain Female 32 T. saginata + +
8 Spain Female 33 T. saginata + + + +
9 Spain Female 84 T. saginata + +
10 Paraguay Female 48 T. saginata + + + + + + – –
11 Bolivia Female 29 T. saginata + +
12 Nicaragua Female 37 T. saginata + +
13 Colombia Female 43 T. solium + +
14 Ethiopia Female 65 T. saginata + +
15 Unknown Male 35 T. saginata + +
16 Unknown Female 34 T. saginata + +
17 Unknown Male 15 T. saginata + +
18 Unknown Male 47 T. saginata + +
aSn-HDP2 cPCR amplicons were sequenced
Key: + positive; − negative
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cPCR ribosomal primers and walking primers (Additional
file 3: Table S3) were used to directly clone and sequence
the T. solium HDP2 amplification product. The DNA
from recombinant plasmids was prepared using standard
protocols. Sequencing, sequence data alignments and
other analyses were performed as previously described
[14, 17, 18].
Results and discussion
Sn-HDP2 cPCR and Sn-HDP2 qPCR amplified T. sagi-
nata and T. solium DNA with an analytical sensitivity of
40 fg and 400 fg, respectively, which was maintained in
both protocols. In the case of T. saginata DNA in par-
ticular, sensitivity was comparable to that reported for
other molecular markers [19–21].
Sn-HDP2 cPCR had previously been successfully used
for the diagnosis of neurocysticercosis based on cerebro-
spinal fluid samples from infected Mexican patients [11].
At that time, a species-specific amplification protocol
was not needed, as T. solium larva is the only taeniid
that can invade the human central nervous system.
However, in the case of taeniasis, which is produced by
both taeniids, Sn-HDP2 cPCR yielded an amplicon with
an identical size for both T. saginata and T. solium
DNA [9, 10]; sequencing of the amplification product
was essential for the specific identification of the taeniid
[11, 12]. A new diagnostic amplification protocol was set
up to circumvent the sequencing step by taking advan-
tage of the differences in HDP2 in nucleotides between
the two species. The novel Sn-HDP2 qPCR showed a
distinct melting temperature (Tm) according to the Tae-
nia species analyzed (Tm of 83.30 °C for T. saginata and
86.00 °C for T. solium), and the difference in Tm had
already been detected in the first amplification (Fig. 1b).
Furthermore, for proglottids, the first reaction usually
yielded conclusive diagnostic results in both amplifica-
tion protocols, as was the case in fecal samples when the
parasite material was sufficient. In previous years, other
HDP2 cPCRs protocols were applied for identification of
T. saginata in fecal samples artificially spiked with
known numbers of T. saginata eggs [22]. Moreover, as
indicated above, amplifications of several molecular tar-
gets such as mitochondrial genes (cox1, nad5, nad1,
12S), and ribosomal ITS1 region and 28S and 5.8S genes
[19, 21, 23] were described in various amplification pro-
tocols (cPCR, qPCR, LAMP) using mono- or multiplex
systems, with very good results for the identification of
Taenia spp. [19–21, 23, 24]. In comparison with Triplex
Taq-Man (T3qPCR) [21], Sn-HDP2 qPCR did not need
a labeled probe, although it did not include an internal
PCR control and was not checked with T. asiatica DNA.
In order to confirm the applicability of Sn-HDP2 cPCR
and Sn-HDP2 qPCR in the diagnosis of infected human
samples, proglottids and fecal samples from taeniasis
patients were examined using both PCR assays. The re-
sults obtained are summarized in Table 1. With proglot-
tids, the two PCRs were able to diagnose taeniasis in the
first amplification as follows: T. saginata in patients
from Europe (n = 9), South America (n = 3), Africa (n =
1) and from undetermined regions (n = 4), with ages ran-
ging from 15 to 84 years; T. solium in a 43 year-old
Latin American individual. In the case of fecal samples,
the PCRs yielded positive results, and T. saginata was
identified, even in stools negative for taeniid eggs (Case 3
and Case 10, Table 1). The identification was confirmed
by agarose gel electrophoresis of the cPCR amplification
product (Fig. 1a) followed by amplicon sequencing. Mo-
lecular approaches have already been used in human sam-
ples for the diagnosis of taeniasis in endemic regions, with
excellent specificity and sensitivity [20, 21, 23]. The mo-
lecular identification of a T. solium tapeworm carrier in
the present study is noteworthy, given the epidemiological
consequences of the transmission of cysticercosis [25] and
the possible need for surveillance measures in countries
where the parasite has been eliminated. Today, migration
from taeniid-endemic regions could extend transmission
[26]. In addition, the frequent diagnosis of T. saginata in
the taeniasis patients studied, in accordance with recent
data from Europe [27], suggests the need for better report-
ing of taeniasis/bovine cysticercosis if the disease is to be
better controlled [25].
In-depth analysis and characterization of the proper-
ties of the HDP2 homolog of T. solium were performed
through cloning of the DNA sequence by screening a T.
solium gDNA library with the T. saginata HDP2 homo-
log [14] and through direct cPCR-cloning using T.
solium gDNA and specific ribosomal DNA primers [28].
A positive recombinant phage (phage clone #1, c.14–
15 kb) and a specific genomic amplicon (c.3.0 kb) were
obtained (Fig. 2). To determine which region of the
phage fragment corresponded to the HDP2 sequence,
phage clone #1 DNA was digested by the SalI restriction
enzyme. The digestion yielded four fragments (Fig. 2a:
a.1), two of which were hybridized with the T. saginata
HDP2 sequence probe, namely, subclones #1.1 and #1.2
(Fig. 2a: a.2). T. solium phage subclones #1.1 and #1.2
were 2081 bp and 2799 bp long, respectively (Fig. 2b),
and showed high similarities in their DNA sequences
(GenBank: subclone #1.1: KY750552; subclone #1.2:
KY750553). They also exhibited a high similarity with
the DNA sequence of the T. solium ribosomal amplicon
(3122 bp) cloned by cPCR (Fig. 2c), with few nucleotide
substitutions and small deletions (GenBank: amplicon:
KY750551). The DNA similarities discovered and the
BLAST analysis data confirmed that T. solium HDP2
(3.12 kb) was a ribosomal gene, as was previously sug-
gested for other taeniid homologous HDP2 molecules
[13], when significant similarities between T. saginata
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HDP2 and the repetitive ribosomal sequences Taiwan
Taenia pTTr 3.1, T. saginata pTSgr 3.1 and pTSgr 2.4,
were demonstrated [29]. The T. solium fragment
(3.12 kb) and subclones #1.1 and #1.2, in comparison
with the T. saginata HDP2, lacked the first 900 nt at the
5′ end, as described elsewhere [9], and showed nucleo-
tide substitutions and small deletions. Specifically, the
largest deletion was located in T. solium HDP2 clones
(from 590 to 620 nt).
The T. solium HDP2 structure within the ribosomal
tandem repeats was further studied by restriction en-
zyme mapping based on the characteristics of both
phage subclones and amplicon sequences. Thus, the
rough size of cloned phage 1 was 14–15 kb. Together
with the characteristics of standard rRNA genes de-
termined by BLAST analysis, this phage included two
partial copies of the ribosomal amplicon HDP2 (3.12 kb)
at its 5′ and 3′ ends and the phage subclones #1.2
(2.79 kb) and #1.1 (2.08 kb), which were located in two
different and contiguous non-transcribed sequence/ex-
ternal transcribed repeat (NTS/ETS) regions (Fig. 2b).
Since information on the structural organization of
rDNA sequences in Taenia species is poor, these data
make it possible to conclude that the phage 1 sequence
corresponded to a T. solium ribosomal DNA repeat plus
an NTS/ETS region (Fig. 2b), with the HDP2 fragment
Fig. 1 Diagnosis of human taeniosis using Sn-HDP2 cPCR and Sn-HDP2 qPCR. a Sn-HDP2 cPCR applied to 3× fecal samples from a patient with
taeniasis. Amplification products fractionated on 2% agarose gels and stained by GelRed. First PCR: Lanes 1, 2: fecal sample 1 (positive by microscopy);
Lanes 3, 4: fecal sample 2; Lanes 5, 6: fecal sample 3 (negative by microscopy); Lane 8: T. saginata DNA (positive control); Lane 9: T. solium DNA (positive
control); Lane 10: no DNA (negative control); Lane M: 100 bp DNA Ladder (NIPPON Genetics Europe, Dueren, Germany). Second PCR: Lanes 1, 2: fecal
sample 1; Lanes 3, 4: fecal sample 2; Lanes 5, 6: fecal sample 3; Lanes 8, 9: T. saginata DNA (positive control); Lanes 12, 13: T. solium DNA (positive
control); Lane 14: no DNA (negative control); Lane M: 100 bp DNA Ladder (Genetics). Sn-HDP2 cPCR amplification products were sequenced. b Melting
curves corresponding to the new Sn-HDP2 qPCR (both first and second PCR runs), applied to both T. saginata and T. solium DNA
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being an NTS/ETS unit, according to the description
made for the sequence and structure of the Caenorhab-
ditis elegans rDNA repeat [30]. Therefore, the genomic
variations detected between the characteristics of HDP2
in both taeniids could explain the following: (i) the dif-
ferent hybridization profiles found when the T. saginata
and T. solium gDNAs were hybridized with the labeled
T. saginata HDP2 DNA sequence [8, 9]; (ii) the non-
amplification of T. solium DNA by the R1F1-HDP2-PCR
[9]; and (iii) the differential sensitivity of taeniids deter-
mined by the amplification protocols described in the
present paper.
Finally, the repetitive nature of HDP2 sequences (ribo-
somal NTS/ETS units) and the differences in nucleotide
composition between Taenia species would explain the
diagnostic properties of the molecule as a target in high-
sensitivity, species-specific amplification protocols.
Conclusions
In the present study, Sn-HDP2 cPCR and Sn-HDP2
qPCR based on proglottids and fecal samples were ap-
plied to diagnose taeniasis in humans, even though the
fecal sample did not contain microscopy-proven para-
sitic forms and the proglottid was damaged. Sn-HDP2
qPCR proved to be the better diagnostic option. The
finding of a T. solium tapeworm carrier and the eight
cases of T. saginata was relevant, considering the cru-
cial epidemiological consequences of transmission of
cysticercosis. The cloning and sequencing of the
HDP2 homolog in the T. solium genome confirmed
that the DNA was ribosomal, specifically an NTS/ETS
unit, and explained the differences in performance of
the amplification protocols according to the specific
composition of this genomic region in T. solium and
T. saginata.
Fig. 2 DNA sequence organization and similarities of the T. solium HDP2 fragment. a a.1: Restriction fragment patterns for T. solium recombinant
phage clone 1 DNA digested by SacI (Lane 1); SalI (Lane 2); XbaI (Lane 3); a.2: Southern blot: T. saginata HDP2 DNA sequence digoxigenin-11-
dUTP-labeled hybridization with T. solium recombinant phage clone 1 DNA digested by SacI (Lane 1); SalI (Lane 2); XbaI (Lane 3). b Diagram
showing the genomic organization of the T. solium HDP2 subclones 1.1 and 1.2 and the T. solium HDP2 amplicon, with respect to the structure
of the ribosomal DNA repeats (-18S-ITS1-5.8S-ITS2-28S-NTS/ETS-). c Physical alignment of Taenia HDP2 (NTS/ETS) fragments. The NTS/ETS ribosomal
repeat is represented by a line, with the T. saginata HDP2 unit as the reference sequence. The boxes in grayscale correspond to the percent homology
with the T. saginata HDP2 fragment (black box represents 100% identity). T. solium subclones 1.1 and 1.2 and the ribosomal amplicon are represented
by boxes in different shades of gray according to similarities
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